Kulasingam SL - Search Results

1

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. Kulasingam SL, et al. JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749. JAMA. 2002. PMID: 12365959

2

State-level disparities in cervical cancer prevention and outcomes in the U.S.: A modeling study.

Alarid-Escudero F, Gracia V, Wolf M, Zhao R, Easterly CW, Kim JJ, Canfell K, de Kok IMCM, Barnabas RV, Kulasingam S. Alarid-Escudero F, et al. medRxiv [Preprint]. 2024 Oct 18:2024.06.11.24308795. doi: 10.1101/2024.06.11.24308795. medRxiv. 2024. Update in: J Natl Cancer Inst. 2024 Nov 21:djae298. doi: 10.1093/jnci/djae298 PMID: 38947042 Free PMC article. Updated. Preprint.

3

The need for and acceptability of a cancer training course for medical and nursing students in Tanzania: a convergent mixed methods study.

Mushy SE, Mkoka DA, Lukumay GG, Massae AF, Rohloff CT, Mgopa LR, Mwakawanga DL, Kohli N, Ross MW, Mkonyi E, Trent M, Athumani K, Kulasingam S, Rosser BRS. Mushy SE, et al. BMC Med Educ. 2024 Jun 3;24(1):614. doi: 10.1186/s12909-024-05497-w. BMC Med Educ. 2024. PMID: 38831409 Free PMC article. Clinical Trial.

4

Will New Human Papillomavirus Diagnostics Improve Cervical Cancer Control Efforts?

Kulasingam SL, Koutsky LA. Kulasingam SL, et al. Curr Infect Dis Rep. 2001 Apr;3(2):169-182. doi: 10.1007/s11908-996-0054-0. Curr Infect Dis Rep. 2001. PMID: 11286660

5

Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry?

Baer A, Kiviat NB, Kulasingam S, Mao C, Kuypers J, Koutsky LA. Baer A, et al. Obstet Gynecol. 2002 Jun;99(6):1053-9. doi: 10.1016/s0029-7844(02)01998-1. Obstet Gynecol. 2002. PMID: 12052599

6

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

Kulasingam SL, Myers ER. Kulasingam SL, et al. JAMA. 2003 Aug 13;290(6):781-9. doi: 10.1001/jama.290.6.781. JAMA. 2003. PMID: 12915431

7

Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia.

Harris TG, Kulasingam SL, Kiviat NB, Mao C, Agoff SN, Feng Q, Koutsky LA. Harris TG, et al. Among authors: kulasingam sl. Am J Epidemiol. 2004 May 1;159(9):834-42. doi: 10.1093/aje/kwh115. Am J Epidemiol. 2004. PMID: 15105176

8

Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.

Bidus MA, Maxwell GL, Kulasingam S, Rose GS, Elkas JC, Chernofsky M, Myers ER. Bidus MA, et al. Obstet Gynecol. 2006 May;107(5):997-1005. doi: 10.1097/01.AOG.0000210529.70226.0a. Obstet Gynecol. 2006. PMID: 16648402

9

Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States.

Baseman JG, Kulasingam SL, Harris TG, Hughes JP, Kiviat NB, Mao C, Koutsky LA. Baseman JG, et al. Among authors: kulasingam sl. Am J Obstet Gynecol. 2008 Jul;199(1):26.e1-8. doi: 10.1016/j.ajog.2007.11.051. Epub 2008 Mar 7. Am J Obstet Gynecol. 2008. PMID: 18313636

10

Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.

Harris TG, Miller L, Kulasingam SL, Feng Q, Kiviat NB, Schwartz SM, Koutsky LA. Harris TG, et al. Among authors: kulasingam sl. Am J Obstet Gynecol. 2009 May;200(5):489.e1-8. doi: 10.1016/j.ajog.2009.01.030. Am J Obstet Gynecol. 2009. PMID: 19375566 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters